From Casetext: Smarter Legal Research

Sabby Volatility Warrant Master Fund Ltd. v. Kiromic Biopharma, Inc.

United States District Court, S.D. New York
Nov 2, 2022
22 CIVIL 1927 (SDA) (S.D.N.Y. Nov. 2, 2022)

Opinion

22 CIVIL 1927 (SDA)

11-02-2022

Sabby Volatility Warrant Master Fund Ltd., et al., Plaintiffs, v. Kiromic Biopharma, Inc., et al., Defendants.


JUDGMENT

It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated November 2, 2022, the Court finds that the statutory prerequisites for a Section 3(a)(10) exemption are satisfied and the Consent Motion is hereby GRANTED. Final judgment is entered dismissing the First Amended Complaint. This Court shall retain jurisdiction, pursuant to 28 U.S.C. § 636(c), to resolve any issues relating to the Order; accordingly, the case is closed.


Summaries of

Sabby Volatility Warrant Master Fund Ltd. v. Kiromic Biopharma, Inc.

United States District Court, S.D. New York
Nov 2, 2022
22 CIVIL 1927 (SDA) (S.D.N.Y. Nov. 2, 2022)
Case details for

Sabby Volatility Warrant Master Fund Ltd. v. Kiromic Biopharma, Inc.

Case Details

Full title:Sabby Volatility Warrant Master Fund Ltd., et al., Plaintiffs, v. Kiromic…

Court:United States District Court, S.D. New York

Date published: Nov 2, 2022

Citations

22 CIVIL 1927 (SDA) (S.D.N.Y. Nov. 2, 2022)